Carolina Barbosa

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

A time and motion study of screening, brief intervention, and referral to treatment implementation in health-care settings

The cost-effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States

SBIRT implementation for adolescents in urban federally qualified health centers: Implementation outcomes

Commentary on Zur & Zaric and Shepard et al. (2016): Cost-effectiveness of SBI for alcohol–where are we and where do we want to go

Cost of screening, brief intervention, and referral to treatment in health care settings

SBIRT implementation for adolescents in urban federally qualified health centers

Return on investment of a work-family intervention: Evidence from the work, family, and health network

The Cost-effectiveness of Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Emergency and Outpatient Medical Settings.

Cost-effectiveness analysis of the national perinatal hepatitis B prevention program.

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: A Markov model

Costs of a Work-Family Intervention: Evidence from the Work, Family, and Health Network

Methodological assessment of economic evaluations of alcohol treatment: What is missing?

Modelling lifetime QALYs and health care costs from different drinking patterns over time: a modified Markov model

Avaliação económica aplicada aos medicamentos

Cost-effectiveness analysis of an HPV-16/18 prophylactic cervical cancer vaccine in a setting of existing screening in Portugal–results from a mathematical model